Delivery Order SPE2DE21D7010-SPE2D626F55B1
- Not listed
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a delivery order on November 3, 2025, for RELINE MAS IMPLANTS with a ceiling value of $22,376.93 and an ultimate completion date of November 24, 2025. This fixed-price contract with economic price adjustment was issued without set-aside designation by the Defense Logistics Agency Medical Supply Chain, a component of the Department of Defense responsible for procuring medical...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a delivery order valued at $4,682.23 on December 5, 2025, for RELINE MAS IMPLANTS through the Defense Logistics Agency (DLA) Medical Supply Chain. The contract is structured as a fixed-price delivery order with economic price adjustment provisions and carries an ultimate completion date of December 30, 2025. No set-aside designation was used in this competitive procurement....
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a $34,087.06 delivery order (4570297341) by the Defense Logistics Agency Medical Supply Chain on December 15, 2025, for the supply of RELINE-ONE spinal implant products. The contract is structured as a fixed-price delivery order with economic price adjustment provisions and carries an ultimate completion date of December 16, 2025. This award was issued under open market...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a fixed-price delivery order valued at $12,607.94 by the Defense Logistics Agency (DLA) Medical Supply Chain on December 12, 2025. This delivery order, with an ultimate completion date of January 5, 2026, covers the procurement of RELINE OPEN IMPLANTS—specialized spinal surgical implants designed to support advanced orthopedic and neurosurgical procedures. The award was...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a delivery order valued at $15,124.90 on November 12, 2025, for RELINE MAS IMPLANTS under contract number 4569992779. The contract utilizes fixed-price pricing with economic price adjustment mechanisms and carries an ultimate completion date of December 3, 2025. This delivery order was issued without set-aside designation through the Defense Logistics Agency Medical Supply...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a $25,055.23 delivery order (Contract No. 4570398009) by the Defense Logistics Agency (DLA) Medical Supply Chain on December 23, 2025, with an ultimate completion date of January 22, 2026. The delivery order is for RELINE OPEN IMPLANTS, spinal surgical devices that support advanced orthopedic and neurosurgical procedures across Department of Defense and Department of Veterans...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a $12,607.94 fixed-price delivery order (contract number 4570040417) by the Defense Logistics Agency Medical Supply Chain on November 13, 2025, for RELINE OPEN IMPLANTS to be delivered by December 5, 2025. The contract was awarded without set-aside designation through open market competition and includes an economic price adjustment mechanism to accommodate cost fluctuations....
- Nuvasive, Inc., a San Diego-based medical device company specializing in spinal surgery products and implants, was awarded a $12.43K fixed-price delivery order with economic price adjustment for RELINE MAS IMPLANTS by the Defense Logistics Agency (DLA) Medical Supply Chain on September 9, 2025. The contract, with an ultimate completion date of October 3, 2025, carries no set-aside designation, indicating open market competition. Performance will take place in San Diego, California. This delivery...
- Nuvasive, Inc., a San Diego-based medical device manufacturer, was awarded a $13,362.36 fixed-price delivery order (Contract No. 4570340917) on December 10, 2025, for the RELINE-C spinal implant system, with performance scheduled for completion by December 11, 2025, at the company's San Diego, California facility. The contract was funded through the Defense Logistics Agency Medical Supply Chain without set-aside designation, reflecting open competition among qualified medical device suppliers....
- Nuvasive, Inc., a San Diego-based medical device manufacturer specializing in spinal surgery products and implants, has been awarded a $39,829.90 delivery order by the Defense Logistics Agency (DLA) Medical Supply Chain, a defense-focused federal agency. The contract, designated as RELINE-ONE, is structured as a fixed-price delivery order with economic price adjustment mechanisms and carries no set-aside designation, indicating open market competition. The place of performance is San Diego,...
- SPE2DE21D7010Indefinite Delivery Contract
- SPE2DE21D7010-SPE2D626F55B1Delivery Order
Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a $9,533.42 fixed-price delivery order on December 23, 2025, by the Defense Logistics Agency Medical Supply Chain for RELINE MAS Implants. The contract, which carries an ultimate completion date of January 14, 2026, represents a non-set-aside competitive procurement for specialized spinal surgical implants to support Department of Defense and Department of Veterans Affairs healthcare facilities. Performance will be conducted at Nuvasive's primary San Diego, California location. This delivery order incorporates an economic price adjustment mechanism, enabling cost flexibility while maintaining budget certainty for the government's medical supply procurement needs. This award leverages Nuvasive's established position as a critical supplier of advanced spinal medical technologies within the federal healthcare enterprise. The company operates under its parent organization's substantial $8 million Blanket Purchase Agreement with the Defense Health Agency (effective through March 2027), which serves as an Indefinite Delivery/Indefinite Quantity contract vehicle facilitating streamlined procurement of Nuvasive's comprehensive portfolio of spinal fusion devices, implants, surgical instruments, and biologics. Through the DLA Medical Supply Chain and related federal contract vehicles, Nuvasive has demonstrated sustained capability in delivering specialized orthopedic and neurosurgical technologies that directly support the operational readiness and medical mission effectiveness of military and veteran healthcare systems across the nation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.5k | 12/22/25 |